Serial Number
90785551
Owner
In8bio, Inc.Attorney
Mark A. JansenFirst Use Date
Aug 6, 2020
Filing Date
Jun 21, 2021
8 Trademark
Serial Number: 90785551 • Registration: 7762644
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Owner Contact Info
Legal Representation
Correspondence Address
Mark A. Jansen FENWICK & WEST LLP
801 CALIFORNIA STREET
MOUNTAIN VIEW, CA 94041
United States
Trademark Details
Filing Date
June 21, 2021
Registration Date
April 15, 2025
First Use Anywhere
August 6, 2020
First Use in Commerce
August 6, 2020
Published for Opposition
November 2, 2021
Goods & Services
pharmaceutical preparations, namely, oncological preparations; reagent, diagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression
development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment
research, development, and evaluation of new products; pharmaceutical, medicine, and vaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology